We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current KNSA market cap is 1.33B. The company's latest EPS is USD 0.1994 and P/E is 94.13.
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 48.35M | 71.47M | 67.05M | 83.4M | 79.86M |
| Operating Income | -11.2M | -3.15M | -33.2M | 81k | -16.54M |
| Net Income | -12.27M | 14.97M | -13.86M | 25.24M | -17.7M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 38.54M | 220.18M | 270.26M |
| Operating Income | -169.96M | -157.36M | -156.64M | 9.77M | -25.2M |
| Net Income | -161.87M | -161.38M | -157.92M | 183.36M | 14.08M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 442.86M | 484.33M | 483.06M | 526.32M | 519.67M |
| Total Liabilities | 52.77M | 72.68M | 77.94M | 87.48M | 87.78M |
| Total Equity | 390.1M | 411.66M | 405.13M | 438.84M | 431.9M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 254.53M | 349.46M | 232.8M | 459.67M | 526.32M |
| Total Liabilities | 29.11M | 37.53M | 47.76M | 63.52M | 87.48M |
| Total Equity | 225.42M | 311.94M | 185.04M | 396.15M | 438.84M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -4.27M | -8.01M | 8.98M | 13.3M | 3.99M |
| Investing | -37.92M | -2.39M | -14.66M | -29.56M | 25.52M |
| Financing | 90k | 248k | 800k | 1.5M | 3.61M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -158.37M | -136.53M | -126.3M | 5.81M | 13.3M |
| Investing | 49.21M | -23.44M | 128.64M | -8.08M | -29.56M |
| Financing | 84.11M | 227.09M | 5.89M | 2.52M | 1.5M |
| Market Cap | 1.33B |
| Price to Earnings Ratio | 94.13 |
| Price to Sales Ratio | 4.9 |
| Price to Cash Ratio | 12.28 |
| Price to Book Ratio | 3.02 |
| Dividend Yield | - |
| Shares Outstanding | 70.62M |
| Average Volume (1 week) | 242.2k |
| Average Volume (1 Month) | 284.59k |
| 52 Week Change | 17.31% |
| 52 Week High | 22.10 |
| 52 Week Low | 13.56 |
| Spread (Intraday) | 2.83 (13.48%) |
| Company Name | Kiniksa Pharmaceuticals Ltd |
| Address |
clarendon house hamilton HM11 |
| Website | https://www.kiniksa.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
